Literature DB >> 27832911

Endophthalmitis after intravitreal injections. Incidence, management and prognosis.

R Tarragó1, J L Olea2, C Ramírez2, L Escudero2.   

Abstract

OBJECTIVE: To assess the rate of endophthalmitis after intravitreal injection (IVI) in a «clean room» of a single health centre, following the guidelines of the Spanish Vitreo-Retinal Society (SERV). An analysis was performed on the culture specimens, response to treatment, and final outcomes (guidelines).
MATERIAL AND METHODS: A retrospective, observational study was conducted on a consecutive case series of patients diagnosed with infectious endophthalmitis after IVI in a single health centre between 2010 and 2015. Intravitreal and systemic treatment was given following the SERV guidelines. The patients were followed up the case was resolved.
RESULTS: There were 5 cases of endophthalmitis out of 9467 IVI (incidence 0.053%). Positive cultures were obtained in aqueous and/or vitreous fluid in all cases, with Staphylococcus epidermidis being involved in 4 out of 5 cases. In 2 cases, final visual acuity was non-light perception due to intractable retinal detachments after resolution of the infectious process.
CONCLUSIONS: IVI performed in a «clean room» have a low incidence of endophthalmitis. The most common infectious agent was Staphylococcus species. In 2 cases the functional prognosis was poor.
Copyright © 2016 Sociedad Española de Oftalmología. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Anti-vascular endothelial growth factor; Antivascular Endothelial Growth Factor; Endoftalmitis; Endophthalmitis; Intravitreal injection; Inyección intravítrea; Staphylococcus; Vancomicina; Vancomycin; Vitrectomy; Vitrectomía

Mesh:

Substances:

Year:  2016        PMID: 27832911     DOI: 10.1016/j.oftal.2016.09.006

Source DB:  PubMed          Journal:  Arch Soc Esp Oftalmol        ISSN: 0365-6691


  4 in total

Review 1.  In vitro dissolution testing models of ocular implants for posterior segment drug delivery.

Authors:  Muhammad Faris Adrianto; Febri Annuryanti; Clive G Wilson; Ravi Sheshala; Raghu Raj Singh Thakur
Journal:  Drug Deliv Transl Res       Date:  2021-08-11       Impact factor: 5.671

2.  Acute Bacterial Tenonitis and Conjunctivitis following Intravitreal Injection.

Authors:  Lillian Y Huang; Albert O Edwards
Journal:  Case Rep Ophthalmol       Date:  2021-04-30

3.  Vitrectomy for endophthalmitis: 5-year study of outcomes and complications.

Authors:  Guy Simon Negretti; WengOnn Chan; Carlos Pavesio; Mahiul Muhammed Khan Muqit
Journal:  BMJ Open Ophthalmol       Date:  2020-03-24

4.  Treatment outcomes of acute poptoperative infectious endophthalmitis.

Authors:  Kai-Ling Peng; Ya-Hsin Kung; Hui-Shuang Tsai; Tsung-Tien Wu
Journal:  BMC Ophthalmol       Date:  2021-10-29       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.